Magnus Veritas Medical Technologies — MVMT — Regenerative and Orthobiologic Technologies

Technology built on the body's own biology.

Autologous cells, resorbable scaffolds, and signal-driven repair, curated for surgeons who evaluate mechanism before anything else.

One System

The body heals as a system. So does this platform.

Bone regeneration requires several conditions at once: a mechanically stable segment, osteogenic cells present at the site, a matrix that holds them there, the growth factors that direct their behavior, and the signaling that drives them to build. Every technology in this catalog addresses one of those conditions, and several address more than one.

The carbohydrate polymer matrix at the center of the platform was originally developed as a substrate for stem cell culture and differentiation. In the graft site it does the same work: it recruits osteogenic cells and binds endogenous growth factors, including BMP-2, concentrating and retaining that biologic signal exactly where repair needs to happen rather than letting it disperse. Load it with the patient's own marrow aspirate and the cells stay where you put them.

Around that, interbody fixation establishes and holds the mechanical environment fusion depends on. Capacitive-coupling stimulation opens voltage-gated calcium channels to drive osteogenesis at the cellular level. Platelet concentrate delivers growth-factor support to surrounding soft tissue. And because the matrix begins radiolucent and turns radiopaque as fusion progresses, healing becomes visible in real time rather than inferred months later.

StructureInterbody fixation, cervical and lumbar
CellsAutologous marrow aspirate concentrate
RetentionOsteoconductive polymer carrier
SignalCapacitive-coupling stimulation
EnvironmentPlatelet growth-factor concentrate
VerificationPoint-of-care imaging

Individually, each is a proven adjunct. Assembled deliberately, they support the full biological cascade the body already runs.

MVMT shield mark over a molecular network
Who We Are
An independent distributor, not tied to a single manufacturer. The recommendation fits the patient, not a quota.
California · Oklahoma · Arkansas · Texas Founder-led, independent distributor est. 2022 Direct manufacturer & executive access
Areas We Serve

Six categories. One point of contact.

The Standard

Selected on mechanism, proven in outcomes.

Every technology in this catalog is evaluated the way a surgeon would evaluate it: mechanism first, then what the data actually shows. A few examples of what's already in the catalog.

31%
Increase in fusion success, bone growth stimulation
83%
Platelet capture rate, PRP concentration
2.33x
Greater likelihood of a successful outcome, bone growth stimulation
See the Full Data
Why MVMT

New tools, no extra admin.

You don't need to take on the paperwork to try something new. We bring the technology, the clinical rationale, and the people who built it, then handle the logistics once you're ready to move.

Direct access to the source

Questions about mechanism or data go straight to the founders or clinical leads behind the technology, not a call center.

We run point on VAC

Value analysis committee submissions, documentation, and follow-up are handled on our side from start to finish.

Independent, not captive

We're not tied to a single manufacturer, so the recommendation is based on fit for your patients, not a quota.

Serving CA, OK, AR, and TX

Active supplier relationships and contracts already in place across all four territories.

MVMT founder

"

Every technology on this platform, I can put a surgeon in the room with the people who developed it. Questions about mechanism deserve answers from the scientists who did the work, not a brochure.

Justin Corbett, Founder